Nektar Therapeutics is a biopharmaceutical company based in San Francisco, California, that discovers and develops medicines using its expertise in polymer chemistry and drug conjugation. It works on treatments for cancer and autoimmune and inflammatory conditions, and its research has included engineered versions of immune-signalling proteins and other drug candidates designed to improve how medicines behave in the body. The company carries out preclinical and clinical development and works with partners on some programmes.
The shares are listed on the London Exchange in UK under the code 0UNL, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3605 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
11/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-42.7%
From 52-week high-63.6%
MomentumWeak
12/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-46.6%
6-month return-58.1%
12-month, skipping last month-8.4%
Stability (higher is calmer)Weak
11/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)79.2%
Worst drawdown, 1 year (smaller is calmer)-64.7%
LiquidityWeak
30/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.10M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 28.70 – 109.01Daily closes, split-adjusted
Signals
50-day average59.37
200-day average64.76
Golden/death cross (60d)Death, 7 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)2.83
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
2 bullish · 0 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
37.80
Bearish
EMA 10
38.88
Bearish
SMA 20
42.61
Bearish
EMA 20
43.50
Bearish
SMA 50
59.37
Bearish
EMA 50
53.95
Bearish
SMA 100
63.29
Bearish
EMA 100
60.16
Bearish
SMA 200
64.76
Bearish
EMA 200
60.25
Bearish
Oscillators (daily)
RSI (14)
28.10
Bullish
MACD (12, 26)
-6.60
Bearish
Momentum (12)
-4.84
Bearish
Stochastic %K (14)
18.37
Bullish
Williams %R (14)
-81.63
Bullish
CCI (20)
-60.14
Neutral
Pivot points (classic, last session)
S3
34.36
S2
35.54
S1
36.33
Pivot
37.51
R1
38.30
R2
39.48
R3
40.27
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
